Mark Pruzanski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Pruzanski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Pruzanski. Mark Pruzanski is CEO & President in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and President & CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT) and President and CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT) and See Remarks in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Equillium, Inc. ($EQ).
Latest Insider Trading Transactions of Mark Pruzanski
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EQ | Equillium, Inc. | Pruzanski Mark | Director | Option Exercise | A | 6.55 | 20,770 | 136,044 | 20,770 | |
| May 04 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 19.78 | 3,817 | 75,500 | 502,649 | 506.5 K to 502.6 K (-0.75 %) |
| May 04 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 19.78 | 6,138 | 121,410 | 506,466 | 500.3 K to 506.5 K (+1.23 %) |
| Apr 01 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 23.08 | 3,658 | 84,427 | 500,328 | 504 K to 500.3 K (-0.73 %) |
| Apr 01 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 23.08 | 6,136 | 141,619 | 503,986 | 497.9 K to 504 K (+1.23 %) |
| Feb 02 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 35.24 | 2,741 | 96,593 | 494,453 | 497.2 K to 494.5 K (-0.55 %) |
| Feb 02 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 35.24 | 6,138 | 216,303 | 497,194 | 491.1 K to 497.2 K (+1.25 %) |
| Jul 06 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 46.52 | 772 | 35,913 | 476,289 | 477.1 K to 476.3 K (-0.16 %) |
| Apr 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 58.40 | 568 | 33,171 | 477,061 | 477.6 K to 477.1 K (-0.12 %) |
| Jan 27 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | A | 99.66 | 17,700 | 1,763,982 | 17,700 | |
| Jan 27 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Grant | A | 0.00 | 10,800 | 0 | 477,629 | 466.8 K to 477.6 K (+2.31 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 21.50 | 100 | 2,150 | 30,084 | |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 123.92 | 1,166 | 144,491 | 466,829 | 468 K to 466.8 K (-0.25 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 123.92 | 1,131 | 140,154 | 467,995 | 469.1 K to 468 K (-0.24 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 125.00 | 100 | 12,500 | 469,126 | 469.2 K to 469.1 K (-0.02 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 21.50 | 100 | 2,150 | 469,226 | 469.1 K to 469.2 K (+0.02 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 21.50 | 417 | 8,966 | 30,184 | |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 125.00 | 417 | 52,125 | 469,126 | 469.5 K to 469.1 K (-0.09 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 21.50 | 417 | 8,966 | 469,543 | 469.1 K to 469.5 K (+0.09 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 21.50 | 15,557 | 334,476 | 30,601 | |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 19,880 | 172,294 | 0 | |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 14,524 | 125,875 | 19,880 | |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 39 | 338 | 0 | |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.00 | 35,437 | 3,543,700 | 469,126 | 504.6 K to 469.1 K (-7.02 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 21.50 | 15,557 | 334,476 | 504,563 | 489 K to 504.6 K (+3.18 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 19,880 | 172,294 | 489,006 | 469.1 K to 489 K (+4.24 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.00 | 14,563 | 1,456,300 | 469,126 | 483.7 K to 469.1 K (-3.01 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 14,524 | 125,875 | 483,689 | 469.2 K to 483.7 K (+3.10 %) |
| Nov 27 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 39 | 338 | 469,165 | 469.1 K to 469.2 K (+0.01 %) |
| Oct 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 65.87 | 1,547 | 101,901 | 469,126 | 470.7 K to 469.1 K (-0.33 %) |
| Jul 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 79.17 | 1,548 | 122,555 | 470,673 | 472.2 K to 470.7 K (-0.33 %) |
| Jun 13 2019 | EQ | Equillium, Inc. | Pruzanski Mark | Director | Option Exercise | A | 6.01 | 12,000 | 72,120 | 12,000 | |
| Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 111.50 | 1,547 | 172,491 | 472,221 | 473.8 K to 472.2 K (-0.33 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | A | 110.80 | 13,700 | 1,517,960 | 13,700 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Grant | A | 0.00 | 8,500 | 0 | 573,768 | 565.3 K to 573.8 K (+1.50 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 100.79 | 1,537 | 154,914 | 565,268 | 566.8 K to 565.3 K (-0.27 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 27,606 | 239,253 | 39 | |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 22,394 | 194,082 | 27,645 | |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 103.29 | 1,988 | 205,333 | 566,805 | 568.8 K to 566.8 K (-0.35 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 102.61 | 7,839 | 804,374 | 568,793 | 576.6 K to 568.8 K (-1.36 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 101.48 | 7,949 | 806,687 | 576,632 | 584.6 K to 576.6 K (-1.36 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.38 | 9,830 | 986,735 | 584,581 | 594.4 K to 584.6 K (-1.65 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 27,606 | 239,253 | 594,411 | 566.8 K to 594.4 K (+4.87 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 101.13 | 3,521 | 356,088 | 566,805 | 570.3 K to 566.8 K (-0.62 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.38 | 18,873 | 1,894,496 | 570,326 | 589.2 K to 570.3 K (-3.20 %) |
| Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 22,394 | 194,082 | 589,199 | 566.8 K to 589.2 K (+3.95 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 126.46 | 2,049 | 259,117 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 83.91 | 2,051 | 172,099 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 61.52 | 2,050 | 126,116 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 58.42 | 3,609 | 210,838 | 566,805 | 570.4 K to 566.8 K (-0.63 %) |
| Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | P | 64.00 | 7,812 | 499,968 | 576,564 | 568.8 K to 576.6 K (+1.37 %) |
| Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | P | 64.00 | 7,812 | 499,968 | 576,564 | 568.8 K to 576.6 K (+1.37 %) |
| Feb 22 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | A | 58.74 | 45,500 | 2,672,670 | 45,500 | |
| Oct 04 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 58.87 | 1,532 | 90,189 | 568,752 | 570.3 K to 568.8 K (-0.27 %) |
| Jul 05 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 121.78 | 1,434 | 174,633 | 570,284 | 571.7 K to 570.3 K (-0.25 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 40,000 | 346,668 | 50,039 | |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 133.08 | 2,043 | 271,872 | 571,718 | 573.8 K to 571.7 K (-0.36 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 132.54 | 5,485 | 726,996 | 573,761 | 579.2 K to 573.8 K (-0.95 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 131.18 | 5,893 | 773,050 | 579,246 | 585.1 K to 579.2 K (-1.01 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 130.46 | 18,763 | 2,447,845 | 585,139 | 603.9 K to 585.1 K (-3.11 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 129.49 | 7,816 | 1,012,101 | 603,902 | 611.7 K to 603.9 K (-1.28 %) |
| Jun 28 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 40,000 | 346,668 | 611,718 | 571.7 K to 611.7 K (+7.00 %) |
| Apr 05 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 115.00 | 1 | 115 | 571,718 | 571.7 K to 571.7 K (0.00 %) |
| Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | A | 107.18 | 40,000 | 4,287,200 | 40,000 | |
| Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Grant | A | 0.00 | 23,200 | 0 | 575,905 | 552.7 K to 575.9 K (+4.20 %) |
| Jan 05 2017 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 103.92 | 2,802 | 291,181 | 552,705 | 555.5 K to 552.7 K (-0.50 %) |
| Dec 08 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 31.90 | 2,405 | 76,720 | 1,354 | |
| Dec 08 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 21.50 | 1,082 | 23,263 | 0 | |
| Dec 08 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 31.90 | 2,405 | 76,720 | 555,507 | 553.1 K to 555.5 K (+0.43 %) |
| Dec 08 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 21.50 | 1,082 | 23,263 | 553,102 | 552 K to 553.1 K (+0.20 %) |
| Oct 05 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 163.20 | 705 | 115,056 | 552,020 | 552.7 K to 552 K (-0.13 %) |
| Sep 22 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 9.88 | 8,411 | 83,120 | 0 | |
| Sep 22 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 26,589 | 230,439 | 90,039 | |
| Sep 22 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 165.00 | 35,000 | 5,775,000 | 552,725 | 587.7 K to 552.7 K (-5.96 %) |
| Sep 22 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 9.82 | 8,411 | 82,615 | 587,725 | 579.3 K to 587.7 K (+1.45 %) |
| Sep 22 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 26,589 | 230,439 | 579,314 | 552.7 K to 579.3 K (+4.81 %) |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 9.82 | 12,500 | 122,779 | 0 | |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Payment of Exercise | F | 148.73 | 7,341 | 1,091,827 | 552,725 | 560.1 K to 552.7 K (-1.31 %) |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 9.82 | 12,500 | 122,779 | 560,066 | 547.6 K to 560.1 K (+2.28 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 145.11 | 714 | 103,608 | 547,566 | 548.3 K to 547.6 K (-0.13 %) |
| Apr 06 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 130.76 | 708 | 92,578 | 548,248 | 549 K to 548.2 K (-0.13 %) |
| Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | See Remarks | Option Exercise | A | 95.74 | 30,500 | 2,920,070 | 30,500 | |
| Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | See Remarks | Grant | A | 0.00 | 23,300 | 0 | 552,856 | 529.6 K to 552.9 K (+4.40 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 0 | |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 145.90 | 125 | 18,238 | 529,556 | 529.7 K to 529.6 K (-0.02 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 145.90 | 2,001 | 291,953 | 529,681 | 531.7 K to 529.7 K (-0.38 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 531,682 | 526.8 K to 531.7 K (+0.92 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,867 | 0 | 4,868 | |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | A | 161.16 | 32,550 | 5,245,758 | 32,550 | |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 159.04 | 167 | 26,560 | 526,814 | 527 K to 526.8 K (-0.03 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,867 | 0 | 526,981 | 522.1 K to 527 K (+0.93 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Grant | A | 0.00 | 15,100 | 0 | 522,114 | 507 K to 522.1 K (+2.98 %) |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 12,500 | 108,334 | 116,628 | |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 250.00 | 12,500 | 3,125,000 | 507,014 | 519.5 K to 507 K (-2.41 %) |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 12,500 | 108,334 | 519,514 | 507 K to 519.5 K (+2.47 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 9,735 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 239.00 | 2 | 478 | 507,014 | 507 K to 507 K (0.00 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 238.16 | 7 | 1,667 | 507,016 | 507 K to 507 K (0.00 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 236.13 | 149 | 35,183 | 507,023 | 507.2 K to 507 K (-0.03 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 507,172 | 502.3 K to 507.2 K (+0.97 %) |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 21.50 | 4,651 | 99,997 | 47,240 | |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 1,910 | 16,553 | 34,404 | |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 21.50 | 4,651 | 99,997 | 502,304 | 497.7 K to 502.3 K (+0.93 %) |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 1,910 | 16,553 | 497,653 | 495.7 K to 497.7 K (+0.39 %) |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 5,000 | 43,334 | 129,128 | |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 300.00 | 5,000 | 1,500,000 | 495,743 | 500.7 K to 495.7 K (-1.00 %) |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 5,000 | 43,334 | 500,743 | 495.7 K to 500.7 K (+1.01 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 12,500 | 108,334 | 134,128 | |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 259.33 | 312 | 80,912 | 495,743 | 496.1 K to 495.7 K (-0.06 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 258.50 | 400 | 103,400 | 496,055 | 496.5 K to 496.1 K (-0.08 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 256.42 | 200 | 51,283 | 496,455 | 496.7 K to 496.5 K (-0.04 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 255.49 | 661 | 168,881 | 496,655 | 497.3 K to 496.7 K (-0.13 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 254.63 | 1,539 | 391,881 | 497,316 | 498.9 K to 497.3 K (-0.31 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 253.53 | 4,338 | 1,099,791 | 498,855 | 503.2 K to 498.9 K (-0.86 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 252.53 | 3,350 | 845,979 | 503,193 | 506.5 K to 503.2 K (-0.66 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 251.39 | 1,700 | 427,368 | 506,543 | 508.2 K to 506.5 K (-0.33 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 12,500 | 108,334 | 508,243 | 495.7 K to 508.2 K (+2.52 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 14,603 | |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 277.70 | 157 | 43,599 | 495,743 | 495.9 K to 495.7 K (-0.03 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 495,900 | 491 K to 495.9 K (+0.99 %) |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 12,500 | 122,779 | 20,911 | |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 12,500 | 122,779 | 0 | |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 52.00 | 25,000 | 1,300,000 | 402,032 | 427 K to 402 K (-5.85 %) |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 12,500 | 122,779 | 427,032 | 414.5 K to 427 K (+3.02 %) |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 12,500 | 122,779 | 414,532 | 402 K to 414.5 K (+3.11 %) |
| May 09 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | A | 31.90 | 65,000 | 2,073,500 | 65,000 | |
| May 09 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Grant | A | 0.00 | 7,700 | 0 | 402,032 | 394.3 K to 402 K (+1.95 %) |
| Nov 20 2012 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | A | 21.50 | 51,922 | 1,116,323 | 51,922 | |
| Nov 20 2012 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | A | 0.00 | 77,884 | 0 | 77,884 |
Page: 1